




Searching News Database: Navelbine
HSMN NewsFeed - 1 Mar 2010
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
HSMN NewsFeed - 16 Nov 2007
ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
HSMN NewsFeed - 10 Oct 2007
ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
HSMN NewsFeed - 8 May 2006
Hana Biosciences Completes Licensing of Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
Hana Biosciences Completes Licensing of Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
HSMN NewsFeed - 17 Mar 2006
Hana Biosciences to License Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
Hana Biosciences to License Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
Additional items found! 6

Members Archive contains
6 additional stories matching:
Navelbine
(Password required)
Navelbine
(Password required)